UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or Section 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 20, 2021
PERIDOT ACQUISITION CORP.
(Exact name of registrant as specified in its charter)
| Cayman Islands | 001-39551 | 85-2505555 | ||
| (State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification Number) |
2229 San Felipe Street, Suite 1450
Houston, TX 77019
(713) 322-7310
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbols |
Name of each exchange on which registered | ||
| Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant | PDAC.U | New York Stock Exchange | ||
| Class A ordinary shares included as part of the units | PDAC | New York Stock Exchange | ||
| Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 | PDAC WS | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 20, 2021, Dr. Varun Sivaram informed the Board of Directors (the “Board”) of Peridot Acquisition Corp., a Cayman islands exempted company (the “Company”), of his intention to resign as a director of the Company effective immediately. Dr. Sivaram expects to serve as an advisor to the administration of United States President Joseph R. Biden, Jr., and his resignation was not due to any disagreement with the Company. Jonathan Silver is expected to replace Dr. Sivaram as the chairperson of the Nominating and Corporate Governance Committee of the Board.
In order for the Company to maintain a board comprised of a majority of independent directors as required by the New York Stock Exchange, Mr. Tomas Ackerman has also resigned as a member of the Board, effective immediately.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 21, 2021
| PERIDOT ACQUISITION CORP. | ||
| By: | /s/ Markus Specks | |
| Name: | Markus Specks | |
| Title: | Chief Financial Officer | |